Pharmaceuticals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide

Datamonitor's Pharmaceuticals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in Brazil, Hungary, Mexico, Poland, South Africa, and Taiwan. The report includes easily comparable data on market value, volume, segmentation and market share for the advanced emerging markets pharmaceuticals markets, plus full five-year market forecasts. It examines future problems, innovations and potential growth areas within the market.


Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Compares data from Brazil, Hungary, Mexico, Poland, South Africa and Taiwan, alongside individual chapters on each country. .

* Includes a five-year forecast of the industry

Highlights

The advanced emerging market countries contributed $37.6 billion to the global pharmaceuticals industry in 2009, with a CAGR of 6.8% between 2005 and 2009.

These countries are expected to reach a value of $50.3 billion in 2014, with a CAGR of 6% over the 2009–14 period.

Brazil is the leading country in the pharmaceuticals industry, with market revenues of $12 billion in 2009.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

In this report, the pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant annual average exchange rates.

Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 16
1.1 What is this report about? 16
1.2 Who is the target reader? 16
1.3 How to use this report 16
1.4 Definitions 16
CHAPTER 2 ADVANCED EMERGING MARKETS PHARMACEUTICALS INDUSTRY OUTLOOK 17
CHAPTER 3 PHARMACEUTICALS IN BRAZIL 24
3.1 Market Overview 24
3.2 Market Value 25
3.3 Market Segmentation I 26
3.4 Market Segmentation II 27
3.5 Market Share 28
3.6 Five Forces Analysis 29
3.7 Leading Companies 37
3.8 Market Forecasts 45
3.9 Macroeconomic Indicators 46
CHAPTER 4 PHARMACEUTICALS IN HUNGARY 48
4.1 Market Overview 48
4.2 Market Value 49
4.3 Market Segmentation I 50
4.4 Market Segmentation II 51
4.5 Market Share 52
4.6 Five Forces Analysis 53
4.7 Leading Companies 62
4.8 Market Forecasts 71
4.9 Macroeconomic Indicators 72
CHAPTER 5 PHARMACEUTICALS IN MEXICO 74
5.1 Market Overview 74
5.2 Market Value 75
5.3 Market Segmentation I 76
5.4 Market Segmentation II 77
5.5 Market Share 78
5.6 Five Forces Analysis 79
5.7 Leading Companies 87
5.8 Market Forecasts 97
5.9 Macroeconomic Indicators 98
CHAPTER 6 PHARMACEUTICALS IN POLAND 100
6.1 Market Overview 100
6.2 Market Value 101
6.3 Market Segmentation I 102
6.4 Market Segmentation II 103
6.5 Market Share 104
6.6 Five Forces Analysis 105
6.7 Leading Companies 114
6.8 Market Forecasts 122
6.9 Macroeconomic Indicators 123
CHAPTER 7 PHARMACEUTICALS IN SOUTH AFRICA 125
7.1 Market Overview 125
7.2 Market Value 126
7.3 Market Segmentation 127
7.4 Market Share 128
7.5 Five Forces Analysis 129
7.6 Leading Companies 137
7.7 Market Forecasts 147
7.8 Macroeconomic Indicators 148
CHAPTER 8 PHARMACEUTICALS IN TAIWAN 150
8.1 Market Overview 150
8.2 Market Value 151
8.3 Market Segmentation I 152
8.4 Market Segmentation II 153
8.5 Market Share 154
8.6 Five Forces Analysis 155
8.7 Leading Companies 162
8.8 Market Forecasts 171
8.9 Macroeconomic Indicators 172
CHAPTER 9 APPENDIX 174
9.1 Data Research Methodology 174

LIST OF TABLES
Table 1: Advanced emerging markets pharmaceuticals industry, revenue ($bn), 2005–14 17
Table 2: Advanced emerging markets pharmaceuticals industry, revenue by country ($bn), 2005–09 20
Table 3: Advanced emerging markets pharmaceuticals industry forecast, revenue by country ($bn), 2009–14 23
Table 4: Brazil Pharmaceuticals Market Value: $ billion, 2005-2009 25
Table 5: Brazil Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 26
Table 6: Brazil Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 27
Table 7: Brazil Pharmaceuticals Market Share: % Share, by Value, 2009 28
Table 8: Key Facts: Novartis AG 37
Table 9: Key Financials: Novartis AG 39
Table 10: Key Facts: GlaxoSmithKline Plc 40
Table 11: Key Financials: GlaxoSmithKline Plc 43
Table 12: Key Facts: EMS Sigma Pharma 44
Table 13: Brazil Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 45
Table 14: Brazil Size of Population (million) , 2005-2009 46
Table 15: Brazil GDP (Current Prices, $ billion), 2005-2009 46
Table 16: Brazil Inflation, 2005-2009 47
Table 17: Brazil Exchange Rate, 2005-2009 47
Table 18: Hungary Pharmaceuticals Market Value: $ billion, 2005-2009 49
Table 19: Hungary Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 50
Table 20: Hungary Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 51
Table 21: Hungary Pharmaceuticals Market Share: % Share, by Value, 2009 52
Table 22: Key Facts: EGIS Pharmaceuticals Plc 62
Table 23: Key Financials: EGIS Pharmaceuticals Plc 64
Table 24: Key Facts: Novartis AG 65
Table 25: Key Financials: Novartis AG 67
Table 26: Key Facts: Gedeon Richter Ltd 68
Table 27: Key Financials: Gedeon Richter Ltd 70
Table 28: Hungary Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 71
Table 29: Hungary Size of Population (million) , 2005-2009 72
Table 30: Hungary GDP (Current Prices, $ billion), 2005-2009 72
Table 31: Hungary Inflation, 2005-2009 73
Table 32: Hungary Exchange Rate, 2005-2009 73
Table 33: Mexico Pharmaceuticals Market Value: $ billion, 2005-2009 75
Table 34: Mexico Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 76
Table 35: Mexico Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 77
Table 36: Mexico Pharmaceuticals Market Share: % Share, by Value, 2009 78
Table 37: Key Facts: Pfizer 87
Table 38: Key Financials: Pfizer 89
Table 39: Key Facts: GlaxoSmithKline Plc 90
Table 40: Key Financials: GlaxoSmithKline Plc 93
Table 41: Key Facts: Eli Lilly and Company 94
Table 42: Key Financials: Eli Lilly and Company 96
Table 43: Mexico Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 97
Table 44: Mexico Size of Population (million) , 2005-2009 98
Table 45: Mexico GDP (Current Prices, $ billion), 2005-2009 98
Table 46: Mexico Inflation, 2005-2009 99
Table 47: Mexico Exchange Rate, 2005-2009 99
Table 48: Poland Pharmaceuticals Market Value: $ billion, 2005-2009 101
Table 49: Poland Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 102
Table 50: Poland Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 103
Table 51: Poland Pharmaceuticals Market Share: % Share, by Value, 2009 104
Table 52: Key Facts: GlaxoSmithKline Plc 114
Table 53: Key Financials: GlaxoSmithKline Plc 117
Table 54: Key Facts: Novartis AG 118
Table 55: Key Financials: Novartis AG 120
Table 56: Key Facts: Les Laboratoires Servier 121
Table 57: Poland Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 122
Table 58: Poland Size of Population (million) , 2005-2009 123
Table 59: Poland GDP (Current Prices, $ billion), 2005-2009 123
Table 60: Poland Inflation, 2005-2009 124
Table 61: Poland Exchange Rate, 2005-2009 124
Table 62: South Africa Pharmaceuticals Market Value: $ billion, 2005-2009 126
Table 63: South Africa Pharmaceuticals Market Segmentation: % Share, by Value, 2009 127
Table 64: South Africa Pharmaceuticals Market Share: % Share, by Value, 2009 128
Table 65: Key Facts: Aspen Pharmacare Holdings Ltd 137
Table 66: Key Financials: Aspen Pharmacare Holdings Ltd 139
Table 67: Key Facts: GlaxoSmithKline Plc 140
Table 68: Key Financials: GlaxoSmithKline Plc 143
Table 69: Key Facts: Pfizer 144
Table 70: Key Financials: Pfizer 146
Table 71: South Africa Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 147
Table 72: South Africa Size of Population (million) , 2005-2009 148
Table 73: South Africa GDP (Current Prices, $ billion), 2005-2009 148
Table 74: South Africa Inflation, 2005-2009 149
Table 75: South Africa Exchange Rate, 2005-2009 149
Table 76: Taiwan Pharmaceuticals Market Value: $ million, 2005-2009 151
Table 77: Taiwan Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 152
Table 78: Taiwan Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 153
Table 79: Taiwan Pharmaceuticals Market Share: % Share, by Value, 2009 154
Table 80: Key Facts: Pfizer Inc. 162
Table 81: Key Financials: Pfizer Inc. 164
Table 82: Key Facts: GlaxoSmithKline Plc 165
Table 83: Key Financials: GlaxoSmithKline Plc 168
Table 84: Key Facts: Yung Shin Pharmaceutical Industry Co., Ltd. 169
Table 85: Key Facts: ScinoPharm Taiwan, LTD. 170
Table 86: Taiwan Pharmaceuticals Market Value Forecast: $ million, 2009-2014 171
Table 87: Taiwan Size of Population (million) , 2005-2009 172
Table 88: Taiwan GDP (Current Prices, $ billion), 2005-2009 172
Table 89: Taiwan Inflation, 2005-2009 173
Table 90: Taiwan Exchange Rate, 2005-2009 173

LIST OF FIGURES
Figure 1: Advanced emerging markets pharmaceuticals industry, revenue ($bn), 2005–14 17
Figure 2: Advanced emerging markets pharmaceuticals industry, country analysis (%), 2005–14 19
Figure 3: Advanced emerging markets pharmaceuticals industry, revenue by country ($bn), 2005–09 20
Figure 4: Advanced emerging markets pharmaceuticals industry forecast, revenue by country ($bn), 2009–14 22
Figure 5: Brazil Pharmaceuticals Market Value: $ billion, 2005-2009 25
Figure 6: Brazil Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 26
Figure 7: Brazil Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 27
Figure 8: Brazil Pharmaceuticals Market Share: % Share, by Value, 2009 28
Figure 9: Forces Driving Competition in the Pharmaceuticals Market in Brazil, 2009 29
Figure 10: Drivers of Buyer Power in the Pharmaceuticals Market in Brazil, 2009 31
Figure 11: Drivers of Supplier Power in the Pharmaceuticals Market in Brazil, 2009 32
Figure 12: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Brazil, 2009 34
Figure 13: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Brazil, 2009 35
Figure 14: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Brazil, 2009 36
Figure 15: Revenues & Profitability: Novartis AG 39
Figure 16: Revenues & Profitability: GlaxoSmithKline Plc 43
Figure 17: Brazil Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 45
Figure 18: Hungary Pharmaceuticals Market Value: $ billion, 2005-2009 49
Figure 19: Hungary Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 50
Figure 20: Hungary Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 51
Figure 21: Hungary Pharmaceuticals Market Share: % Share, by Value, 2009 52
Figure 22: Forces Driving Competition in the Pharmaceuticals Market in Hungary, 2009 53
Figure 23: Drivers of Buyer Power in the Pharmaceuticals Market in Hungary, 2009 55
Figure 24: Drivers of Supplier Power in the Pharmaceuticals Market in Hungary, 2009 57
Figure 25: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Hungary, 2009 59
Figure 26: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Hungary, 2009 60
Figure 27: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Hungary, 2009 61
Figure 28: Revenues & Profitability: EGIS Pharmaceuticals Plc 64
Figure 29: Revenues & Profitability: Novartis AG 67
Figure 30: Revenues & Profitability: Gedeon Richter Ltd 70
Figure 31: Hungary Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 71
Figure 32: Mexico Pharmaceuticals Market Value: $ billion, 2005-2009 75
Figure 33: Mexico Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 76
Figure 34: Mexico Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 77
Figure 35: Mexico Pharmaceuticals Market Share: % Share, by Value, 2009 78
Figure 36: Forces Driving Competition in the Pharmaceuticals Market in Mexico, 2009 79
Figure 37: Drivers of Buyer Power in the Pharmaceuticals Market in Mexico, 2009 81
Figure 38: Drivers of Supplier Power in the Pharmaceuticals Market in Mexico, 2009 82
Figure 39: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Mexico, 2009 84
Figure 40: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Mexico, 2009 85
Figure 41: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Mexico, 2009 86
Figure 42: Revenues & Profitability: Pfizer 89
Figure 45: Mexico Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 97
Figure 46: Poland Pharmaceuticals Market Value: $ billion, 2005-2009 101
Figure 47: Poland Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 102
Figure 48: Poland Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 103
Figure 49: Poland Pharmaceuticals Market Share: % Share, by Value, 2009 104
Figure 50: Forces Driving Competition in the Pharmaceuticals Market in Poland, 2009 105
Figure 51: Drivers of Buyer Power in the Pharmaceuticals Market in Poland, 2009 107
Figure 52: Drivers of Supplier Power in the Pharmaceuticals Market in Poland, 2009 108
Figure 53: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Poland, 2009 110
Figure 54: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Poland, 2009 112
Figure 55: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Poland, 2009 113
Figure 56: Revenues & Profitability: GlaxoSmithKline Plc 117
Figure 57: Revenues & Profitability: Novartis AG 120
Figure 58: Poland Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 122
Figure 59: South Africa Pharmaceuticals Market Value: $ billion, 2005-2009 126
Figure 60: South Africa Pharmaceuticals Market Segmentation: % Share, by Value, 2009 127
Figure 61: South Africa Pharmaceuticals Market Share: % Share, by Value, 2009 128
Figure 62: Forces Driving Competition in the Pharmaceuticals Market in South Africa, 2009 129
Figure 63: Drivers of Buyer Power in the Pharmaceuticals Market in South Africa, 2009 131
Figure 64: Drivers of Supplier Power in the Pharmaceuticals Market in South Africa, 2009 132
Figure 65: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in South Africa, 2009 134
Figure 66: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in South Africa, 2009 135
Figure 67: Drivers of Degree of Rivalry in the Pharmaceuticals Market in South Africa, 2009 136
Figure 68: Revenues & Profitability: Aspen Pharmacare Holdings Ltd 139
Figure 69: Revenues & Profitability: GlaxoSmithKline Plc 143
Figure 70: Revenues & Profitability: Pfizer 146
Figure 71: South Africa Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 147
Figure 72: Taiwan Pharmaceuticals Market Value: $ million, 2005-2009 151
Figure 73: Taiwan Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 152
Figure 74: Taiwan Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 153
Figure 75: Taiwan Pharmaceuticals Market Share: % Share, by Value, 2009 154
Figure 76: Forces Driving Competition in the Pharmaceuticals Market in Taiwan, 2009 155
Figure 77: Drivers of Buyer Power in the Pharmaceuticals Market in Taiwan, 2009 157
Figure 78: Drivers of Supplier Power in the Pharmaceuticals Market in Taiwan, 2009 158
Figure 79: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Taiwan, 2009 159
Figure 80: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Taiwan, 2009 160
Figure 81: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Taiwan, 2009 161
Figure 82: Revenues & Profitability: Pfizer Inc. 164
Figure 83: Revenues & Profitability: GlaxoSmithKline Plc 168
Figure 84: Taiwan Pharmaceuticals Market Value Forecast: $ million, 2009-2014 171



[Inhaltsverzeichnis ausblenden]